Answers are grounded in this paper and cite their sources.
Public health review reveals shifting etiologies toward nonalcoholic steatohepatitis in chronic liver disease, indicating large-scale alanine aminotransferase screening is urgently needed.
CLDs represent an important, and certainly underestimated, global public health problem. CLDs are highly prevalent and silent, related to different, sometimes associated causes. The distribution of the causes of these diseases is slowly changing, and within the next decade, the proportion of virus-induced CLDs will certainly decrease significantly while the proportion of NASH will increase. There is an urgent need for effective global actions including education, prevention and early diagnosis to manage and treat CLDs, thus preventing cirrhosis-related morbidity and mortality. Our role is to increase the awareness of the public, healthcare professionals and public health authorities to encourage active policies for early management that will decrease the short- and long-term public health burden of these diseases. Because necroinflammation is the key mechanism in the progression of CLDs, it should be detected early. Thus, large-scale screening for CLDs is needed. ALT levels are an easy and inexpensive marker of liver necroinflammation and could be the first-line tool in this process.
No takes yet. Share an insight, caveat, or question.
Marcellin et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: